PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Papatheodoridis, ONUR; Dalekos, George; Sypsa, Vana; Yurdaydin, Cihan; Buti, Maria; Goulis, John; Luis Calleja, Jose; Chi, Heng; Manolakopoulos, Spilios; Mangia, Giampaolo; Gatselis, Nikolaos; KESKİN, ONUR; Savvidou, Savvoula; de la Revilla, Juan; Hansen, Bettina; Vlachogiannakos, Ioannis; Galanis, Kostantinos; İDİLMAN, RAMAZAN; Colombo, Massimo; Esteban, Rafael; Janssen, Harry; Lampertico, Pietro

doi:10.1016/j.jhep.2015.11.035

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Papatheodoridis G., Dalekos G., Sypsa V., Yurdaydin C., Buti M., Goulis J., ...More

JOURNAL OF HEPATOLOGY, vol.64, no.4, pp.800-806, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 64 Issue: 4
Publication Date: 2016
Doi Number: 10.1016/j.jhep.2015.11.035
Journal Name: JOURNAL OF HEPATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.800-806
Hacettepe University Affiliated: No

Abstract

Background & Aims: Risk scores for hepatocellular carcinoma (HCC) developed in Asians offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This nine center cohort study aimed to develop and validate an accurate HCC risk score in Caucasian CHB patients treated with the current oral antivirals, entecavir/tenofovir.